10 series
Export
<<<Page of 1 >>>Page size
Accession Title Series type(s) Organism(s) Samples GDS Supplementary Contact Release date
Remove filtersFilter Remove filterGenome binding/occupancy profiling by high throughput sequencing Remove filterBW Remove filterMatthew Weirauch
GSE184238
Epigenetic and Transcriptional Dysregulation in T cells of patients with Atopic Dermatitis
48 Matthew Weirauch Apr 26, 2022
GSE183257
Epigenetic and Transcriptional Dysregulation in T cells of patients with Atopic Dermatitis [ATAC-seq]
  • Genome binding/occupancy profiling by high throughput sequencing
12 Matthew Weirauch Apr 26, 2022
GSE184301
Epigenetic and Transcriptional Dysregulation in T cells of patients with Atopic Dermatitis [ChIP-seq]
  • Genome binding/occupancy profiling by high throughput sequencing
12 Matthew Weirauch Apr 26, 2022
GSE148396
Epstein-Barr virus nuclear antigen 2 (EBNA2) extensively rewires the human chromatin landscape at autoimmune risk loci
29 Matthew Weirauch Sep 23, 2021
GSE176421
Epstein-Barr virus nuclear antigen 2 (EBNA2) extensively rewires the human chromatin landscape at autoimmune risk loci [ATAC-seq]
  • Genome binding/occupancy profiling by high throughput sequencing
9 Matthew Weirauch Sep 23, 2021
GSE176232
Epstein-Barr virus nuclear antigen 2 (EBNA2) extensively rewires the human chromatin landscape at autoimmune risk loci [ChIP-seq]
  • Genome binding/occupancy profiling by high throughput sequencing
4 Matthew Weirauch Sep 23, 2021
GSE167528
H3K27ac in SARS-CoV-2 infection
  • Genome binding/occupancy profiling by high throughput sequencing
10 Matthew Weirauch Feb 26, 2021
GSE246062
Shared and distinct interactions of Epstein-Barr Nuclear Antigen 2 type 1 and type 2 with the human genome
43 Matthew Weirauch Mar 12, 2024
GSE246059
Shared and distinct interactions of Epstein-Barr Nuclear Antigen 2 type 1 and type 2 with the human genome (ATAC-Seq)
  • Genome binding/occupancy profiling by high throughput sequencing
8 Matthew Weirauch Mar 12, 2024
GSE246060
Shared and distinct interactions of Epstein-Barr Nuclear Antigen 2 type 1 and type 2 with the human genome (ChIP-Seq)
  • Genome binding/occupancy profiling by high throughput sequencing
26 Matthew Weirauch Mar 12, 2024